Cargando…

Effects of Solriamfetol on Quality-of-Life Measures from a 12-Week Phase 3 Randomized Controlled Trial

Rationale: Excessive daytime sleepiness in patients with obstructive sleep apnea is associated with substantial burden of illness. Objectives: To assess treatment effects of solriamfetol, a dopamine/norepinephrine reuptake inhibitor, on daily functioning, health-related quality of life, and work pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weaver, Terri E., Drake, Christopher L., Benes, Heike, Stern, Thomas, Maynard, James, Thein, Stephen G., Andry, James M., Hudson, John D., Chen, Dan, Carter, Lawrence P., Bron, Morgan, Lee, Lawrence, Black, Jed, Bogan, Richard K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393785/ https://www.ncbi.nlm.nih.gov/pubmed/32353246 http://dx.doi.org/10.1513/AnnalsATS.202002-136OC

Ejemplares similares

A randomized study of solriamfetol for excessive sleepiness in narcolepsy
por: Thorpy, Michael J., et al.
Publicado: (2019)

Effects of solriamfetol on on‐the‐road driving in participants with narcolepsy: A randomised crossover trial
por: Vinckenbosch, Frederick, et al.
Publicado: (2022)

A Randomized, Double‐Blind, Placebo‐ and Positive‐Controlled, 4‐Period Crossover Study of the Effects of Solriamfetol on QTcF Intervals in Healthy Participants
por: Zomorodi, Katie, et al.
Publicado: (2020)

P148 Solriamfetol Titration & AdministRaTion (START): Dosing and titration strategies in patients with narcolepsy starting solriamfetol
por: Thorpy, M, et al.
Publicado: (2021)

Solriamfetol for the Use of Narcolepsy: A Systematic Review
por: Iturburu, Alisson, et al.
Publicado: (2022)

Effects of solriamfetol on on‐the‐road driving performance in participants with excessive daytime sleepiness associated with obstructive sleep apnoea
por: Vinckenbosch, Frederick, et al.
Publicado: (2022)

Single‐Dose Pharmacokinetics and Safety of Solriamfetol in Participants With Normal or Impaired Renal Function and With End‐Stage Renal Disease Requiring Hemodialysis
por: Zomorodi, Katie, et al.
Publicado: (2019)

P147 Solriamfetol Titration & AdministRaTion (START): Characteristics of patients with obstructive sleep apnoea (OSA) and prescriber rationale for starting treatment with solriamfetol
por: Singh, H, et al.
Publicado: (2021)

A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor
por: Carter, Lawrence P, et al.
Publicado: (2018)

Solriamfetol impurities: Synthesis, characterization, and analytical method (UPLC-UV) validation
por: Al-Rifai, Nafisah, et al.
Publicado: (2023)

Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof‐of‐Concept Trial
por: Videnovic, Aleksandar, et al.
Publicado: (2021)

Long-term study of the safety and maintenance of efficacy of solriamfetol (JZP-110) in the treatment of excessive sleepiness in participants with narcolepsy or obstructive sleep apnea
por: Malhotra, Atul, et al.
Publicado: (2019)

Pitolisant, a wake‐promoting agent devoid of psychostimulant properties: Preclinical comparison with amphetamine, modafinil, and solriamfetol
por: Krief, Stéphane, et al.
Publicado: (2021)

Randomized Controlled Trial of Solriamfetol for Excessive Daytime Sleepiness in OSA: An Analysis of Subgroups Adherent or Nonadherent to OSA Treatment
por: Schweitzer, Paula K., et al.
Publicado: (2021)

Profile of Solriamfetol in the Management of Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea: Focus on Patient Selection and Perspectives
por: Abad, Vivien C
Publicado: (2021)

Relationship between sleep efficacy endpoints and measures of functional status and health‐related quality of life in participants with narcolepsy or obstructive sleep apnea treated for excessive daytime sleepiness
por: Weaver, Terri E., et al.
Publicado: (2020)

Solriamfetol Titration and AdministRaTion (START) in Patients with Obstructive Sleep Apnea: A Retrospective Chart Review and Hypothetical Patient Scenario
por: Singh, Haramandeep, et al.
Publicado: (2022)

Determination of thresholds for minimally important difference and clinically important response on the functional outcomes of sleep questionnaire short version in adults with narcolepsy or obstructive sleep apnea
por: Weaver, Terri E., et al.
Publicado: (2021)

Structural Models for Roseolovirus U20 And U21: Non-Classical MHC-I Like Proteins From HHV-6A, HHV-6B, and HHV-7
por: Weaver, Grant C., et al.
Publicado: (2022)

Corrigendum: Structural Models for Roseolovirus U20 And U21: Non-Classical MHC-I Like Proteins From HHV-6A, HHV-6B, and HHV-7
por: Weaver, Grant C., et al.
Publicado: (2022)

Oral pressure therapy for treatment of obstructive sleep apnea: clinical feasibility
por: Farid-Moayer, Mehran, et al.
Publicado: (2013)

The 12 week year: get more done in 12 weeks than others do in 12 months
por: Moran, Brian, et al.
Publicado: (2013)

Long-term efficacy and safety of tonic motor activation for treatment of medication-refractory restless legs syndrome: A 24-Week Open-Label Extension Study
por: Roy, Asim, et al.
Publicado: (2023)

Omega-3 Fatty Acid Supplementation for 12 Weeks Increases Resting and Exercise Metabolic Rate in Healthy Community-Dwelling Older Females
por: Logan, Samantha L., et al.
Publicado: (2015)

Evaluation of Quality of Life in Patients With Narcolepsy Treated With Sodium Oxybate: Use of the 36-Item Short-Form Health Survey in a Clinical Trial
por: Bogan, Richard, et al.
Publicado: (2016)

Correlation of Changes in Patient-Reported Quality of Life With Physician-Rated Global Impression of Change in Patients With Narcolepsy Participating in a Clinical Trial of Sodium Oxybate: A Post Hoc Analysis
por: Bogan, Richard K., et al.
Publicado: (2017)

The 12 Week Year Field Guide
por: Moran, Brian
Publicado: (2018)

Analytical and Clinical Evaluation of Two Methods for Measuring Erythrocyte Sedimentation Rate in Eastern Indigo Snakes (Drymarchon couperi)
por: Bogan, James E.
Publicado: (2023)

Knee Extension Range of Motion at 4 Weeks Is Related to Knee Extension Loss at 12 Weeks After Anterior Cruciate Ligament Reconstruction
por: Noll, Sarah, et al.
Publicado: (2015)

Characterization of the Microbiota Associated With 12-Week-Old Bovine Fetuses Exposed to Divergent in utero Nutrition
por: Amat, Samat, et al.
Publicado: (2022)

Synthetic Sex Pheromone in a Long-Lasting Lure Attracts the Visceral Leishmaniasis Vector, Lutzomyia longipalpis, for up to 12 Weeks in Brazil
por: Bray, Daniel P., et al.
Publicado: (2014)

Laparoscopic Removal of Abdominal Cerclage at 19 Weeks' Gestation
por: Carter, James F., et al.
Publicado: (2013)

Early versus 6–12 week Postpartum Glucose Tolerance Testing for Women with Gestational Diabetes
por: Carter, Ebony B., et al.
Publicado: (2017)

Memorandum: Test run in weeks 11, 12
por: Muon Storage Ring Group, et al.
Publicado: (1966)

Lack of effects of fish oil supplementation for 12 weeks on resting metabolic rate and substrate oxidation in healthy young men: A randomized controlled trial
por: Jannas-Vela, Sebastian, et al.
Publicado: (2017)

Incorporation of Omega-3 Fatty Acids Into Human Skeletal Muscle Sarcolemmal and Mitochondrial Membranes Following 12 Weeks of Fish Oil Supplementation
por: Gerling, Christopher J., et al.
Publicado: (2019)

820 Triple Combination Treatment With Peginterferon Lambda-1a, Daclatasvir and Ribavirin for 12 Weeks in Patients Infected With HCV Genotype 1b
por: Brunetto, Maurizia, et al.
Publicado: (2014)

Outcomes of a Mobile Health Coaching Platform: 12-Week Results of a Single-Arm Longitudinal Study
por: Willey, Steven, et al.
Publicado: (2016)

Long-Term Safety and Tolerability of Daridorexant in Patients with Insomnia Disorder
por: Kunz, Dieter, et al.
Publicado: (2022)

Effect of a 6-week and 12-week cardiac rehabilitation program on heart rate recovery
por: El Missiri, Ahmed, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5q4e4u7pli39esmbsib2aog20k